Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Pancreatic cancer: overview
3. Recent celebrity pancreatic cancer deaths
4. The pancreas - an anatomical overview
5. Pancreatic adenocarcinoma
6. Pancreatic cancer: epidemiology
7. Incidence of pancreas cancer
8. Pancreatic cancer risk factors
9. Role of smoking in pancreatic cancer development
10. Pancreatic adenocarcinoma: risk factors moderate
11. Pancreatic adenocarcinoma: risk factors high
12. President Jimmy Carter's family
13. Syndromes associated with pancreatic cancer
14. Phenotypic changes of the skin in FAMMM
15. Familial atypical multiple mole melanoma pedigree
16. Pathology
17. Pancreatic adenocarcinoma: precursor lesions
18. Genetic progression model of pancreatic cancer
19. Ductal adenocarcinoma: gross
20. Ductal adenocarcinoma: micro (1)
21. Ductal adenocarcinoma: micro (2)
22. Ductal adenocarcinoma: micro (3)
23. Ductal adenocarcinoma: micro (4)
24. Cystic neoplasms
25. Serous microcystic adenoma
26. Mucinous cystic tumors
27. Mucinous cystic neoplasm: gross
28. Mucinous cystic neoplasm: micro
29. Intraductal Papillary Mucinous Neoplasm (IPMN)
30. Types of IPMNs
31. IPMN: gross (duct opened)
32. IPMN: MRI scan
33. Branch duct-IPMN with CIS
34. Adenocarcinoma: signs and symptoms (1)
35. Adenocarcinoma: signs and symptoms (2)
36. The difficulty of finding pancreatic cancer early
37. Current status of biomarkers: CA 19-9
38. CA 19-9: effects of selecting different cutoff points
39. CA 19-9 as screening test
40. CA19-9 in symptomatic patients
41. Screening versus surveillance
42. Conventional techniques
43. Sensitivity and specificity of imaging modalities
44. Candidates for pancreatic cancer surveillance
45. Pancreatic adenocarcinoma: staging (1)
46. Pancreatic adenocarcinoma: staging (2)
47. Diagnostic algorithm
48. Pancreatic adenocarcinoma: staging (3)
49. Abdominal CT scan of a pancreatic mass
50. CT angiogram of major abdominal vessels
51. MRI scan of a pancreatic mass
52. MRCP of the biliary ductal system
53. Radial and linear echoendoscopes
54. Pancreatic-biliary imaging stations
55. Imaging stations of the stomach
56. Sonography of a mass in the body of pancreas
57. Five-year relative survival rates, 1989-1995
58. Approach to improve on dismal prognosis
59. Prevention of pancreatic cancer
60. Treatment of pancreatic cancer
61. Stages of pancreatic cancer
62. Options for therapy (1)
63. Options for therapy (2)
64. Treatment: pancreatic adenocarcinoma
65. Situations to avoid surgery: pancreatic cancer
66. Adjuvant therapy of pancreatic cancer study
67. Comparing chemotherapy & chemoradiotherapy (1)
68. Comparing chemotherapy & chemoradiotherapy (2)
69. Locally unresectable pancreatic cancer
70. Pivotal trial of gemcitabine vs. 5-FU
71. Mechanism of action of gemcitabine
72. Pancreatic carcinoma: treatment
73. Pancreatic carcinoma: palliation
74. Duodenal obstruction from extrinsic compression
75. Placement of an expandable duodenal stent
76. Pancreatic head cancer with biliary obstruction
77. Pancreatic carcinoma: treatment summary
78. Concluding remarks

Topics Covered

• General epidemiologic data for pancreatic cancer
• Review risk factors for pancreatic cancer
• Clinical presentation and diagnostic modalities for pancreatic cancer
• Current status for early detection, diagnosis and staging of pancreatic cancer
• Treatment of pancreatic cancer

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Cancer
• Clinical Practice

Therapeutic Areas:

• Gastroenterology & Nephrology
• Oncology

Talk Citation

Publication History

• Published on January 5, 2011
• Archived on September 28, 2016

Financial Disclosures

• Prof. Randall Brand, Grant/Research Support (Principal Investigator): Ambry Genetics, supplied research support to cover free genetic testing and costs associated with initiating study at our site as part of a multi-center trial. Study was not discussed in the presentation.